Live Chat

Novavax 거래 NVAX

매도
 매수

Novavax 실시간 차트

5m 15m 30m 1h 4h 1d 1w

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

최신 뉴스

Forex candlestick chart of JPY/USD currency pair trends.
Vanessa L 2025 Jan 17, 10:00

Forex Prop Trading Updates and Income Levels' Impact on Forex

Forex JPY USD
Bitcoin price action is shown on a trading chart, with a British flag in the background.
Vanessa L 2025 Jan 17, 09:00

Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK

Cryptocurrencies
Frances Wang 2025 Jan 16, 16:00

S&P 500 and Nasdaq 100 Update: Strong Earnings Drive Market Gains

Indices
Frances Wang 2025 Jan 16, 16:00

Oil price today: Oil Prices Climb Amid Supply Fears

Oil
Frances Wang 2025 Jan 16, 16:00

Forex market update: GBP/USD, USD/JPY Forecast

Forex
Darius Anucauskas 2025 Jan 16, 16:00

Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration

The person silhouette with fluctuating red and green stock charts, symbolizes uncertainty.
Vanessa L 2025 Jan 16, 11:00

Why Is the Stock Market Going Down Today and Are Interest Rates Going Down?

Stocks Shares
A tanker carrying heating oil on a foggy morning, symbolizes the global energy trade.
Vanessa L 2025 Jan 16, 09:02

What Influences the Price of Heating Oil Per Gallon Today? Insights on Futures Contract Crude Oil

Oil Commodities

정보

스프레드

0.07

스프레드(%)

0.8363 %

레버리지

1:10

익일 이자 매수

-0.0597 %

익일 이자 매도

-0.0292 %

통화

USD

거래 시간

시장 폐장

화요일

14:31 - 20:59

수요일

14:31-20:59

목요일

14:31-20:59

금요일

14:31-20:59

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

1366377984

발행 주식 수

160184992

수익 날짜 (다음)

2019-05-10

배당수익률

2019-05-10

배당락일

예상 연간 배당금

0

예상 연간 배당수익률

0

EPS

-2.18

이 상품에 대해 자세히 알아보기

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

관련 상품

자산
매도
매수
변동(%)

지금 거래하기

지금 거래하기

지금 거래하기

지금 거래하기
view_all_instruments
Trustpilot
Live Chat